Digital transformation is a key component within the National Health Service Maternity Transformation Programme. The COVID-19 pandemic led to an […]
Primary aldosteronism due to a unilateral aldosterone-producing adenoma is a common cause of hypertension. This can be cured or greatly
Post Content
Post Content
Post Content
Canada’s Drug Agency (CDA-AMC) recommends that Polivy in combination with rituximab, cyclophosphamide, doxorubicin , and prednisone (R-CHP) should be reimbursed
Canada’s Drug Agency (CDA-AMC) recommends that Iqirvo be reimbursed by public drug plans for the treatment of primary biliary cholangitis
Canada’s Drug Agency (CDA-AMC) received a request to analyze MRI exam trends over 16 years to inform policy decisions related
Canada’s Drug Agency (CDA-AMC) recommends that Keytruda, in combination with pemetrexed and platinum chemotherapy, be reimbursed by public drug plans
Registration No: 771800548 Contact Number : +91-8249516996
